25:
305:
125:
373:
179:
207:
54:
221:
354:
378:
164:
76:
193:
47:
383:
347:
240:
Biotech
Industry Driven By Evolution Searching For Cures, Companies Get Creative. Carol Smith P-I Reporter.
247:
Mature companies beat out new ones for VC cash. Romano, Benjamin J. Seattle Times. October 25, 2005: C1.
294:
340:
37:
41:
33:
328:
264:"The new virus killer: scientists try to turn HIV's greatest strength--mutation--against itself."
58:
233:
Paulson, Tom. "Conflicts
Advance a Burgeoning Field Industry, Academia Now are Bedfellows."
8:
148:
320:
268:
324:
316:
253:
144:
367:
140:
98:
241:
234:
226:
198:
160:
194:"Koronis' HIV drug draws funding; $ 20 million to be used for studies"
263:
159:. The company also has products in development for the treatment of
143:
company founded in 1998. Koronis is dedicated to the development of
156:
312:
184:
152:
136:
286:
212:
304:
251:
Specter, Michael (December 3, 2007), "Darwin's
Surprise",
124:
180:"U.S. HIV drug firm Koronis looks to London listing"
222:"Biotech pioneer Gillis ventures into a new field"
365:
46:but its sources remain unclear because it lacks
151:(VDA). The Company's lead product candidate is
348:
374:Biotechnology companies of the United States
157:human immunodeficiency virus (HIV) infection
355:
341:
272:, vol. 274, no. 2, pp. 27–
257:, vol. 83, no. 38, pp. 64–
147:therapeutics based on a novel mechanism,
77:Learn how and when to remove this message
123:
250:
366:
205:
177:
299:
261:
219:
191:
18:
13:
14:
395:
278:
206:Dolan, Kerry A. (July 20, 2011),
303:
23:
293:Reuters story on IPO prospects
262:Mone, Gregory (February 2009),
16:American biotechnology company
1:
220:Cook, John (August 2, 2005),
170:
327:. You can help Knowledge by
323:corporation or company is a
192:Cook, John (June 28, 2007),
7:
110:; 26 years ago
10:
400:
379:Companies based in Seattle
298:
104:
94:
149:Viral Decay Acceleration
32:This article includes a
133:Koronis Pharmaceuticals
90:Koronis Pharmaceuticals
61:more precise citations.
129:
384:Medical company stubs
311:This article about a
208:"Embracing The Enemy"
155:for the treatment of
127:
244:. May 17, 1999: A1.
237:. May 19, 1999: A1.
91:
130:
89:
34:list of references
336:
335:
122:
121:
87:
86:
79:
391:
357:
350:
343:
321:biotechnological
307:
300:
290:
289:
287:Official website
273:
258:
230:
216:
202:
188:
178:Hirschler, Ben,
118:
116:
111:
92:
88:
82:
75:
71:
68:
62:
57:this article by
48:inline citations
27:
26:
19:
399:
398:
394:
393:
392:
390:
389:
388:
364:
363:
362:
361:
285:
284:
281:
276:
269:Popular Science
173:
114:
112:
109:
83:
72:
66:
63:
52:
38:related reading
28:
24:
17:
12:
11:
5:
397:
387:
386:
381:
376:
360:
359:
352:
345:
337:
334:
333:
317:pharmaceutical
308:
297:
296:
291:
280:
279:External links
277:
275:
274:
259:
254:The New Yorker
248:
245:
238:
231:
217:
203:
189:
174:
172:
169:
120:
119:
106:
102:
101:
96:
85:
84:
42:external links
31:
29:
22:
15:
9:
6:
4:
3:
2:
396:
385:
382:
380:
377:
375:
372:
371:
369:
358:
353:
351:
346:
344:
339:
338:
332:
330:
326:
322:
318:
314:
309:
306:
302:
301:
295:
292:
288:
283:
282:
271:
270:
265:
260:
256:
255:
249:
246:
243:
239:
236:
232:
229:
228:
223:
218:
215:
214:
209:
204:
201:
200:
195:
190:
187:
186:
181:
176:
175:
168:
166:
165:RSV infection
162:
158:
154:
150:
146:
142:
141:biotechnology
138:
134:
126:
107:
103:
100:
99:Biotechnology
97:
93:
81:
78:
70:
60:
56:
50:
49:
43:
39:
35:
30:
21:
20:
329:expanding it
310:
267:
252:
225:
211:
197:
183:
132:
131:
73:
64:
53:Please help
45:
242:Seattle P-I
235:Seattle P-I
227:Seattle P-I
199:Seattle P-I
161:hepatitis C
67:August 2018
59:introducing
368:Categories
171:References
145:antiviral
95:Industry
313:medical
185:Reuters
153:KP-1461
137:Seattle
128:KP-1461
113: (
105:Founded
55:improve
213:Forbes
139:area
135:is a
40:, or
325:stub
163:and
115:1998
108:1998
319:or
370::
315:,
266:,
224:,
210:,
196:,
182:,
167:.
44:,
36:,
356:e
349:t
342:v
331:.
117:)
80:)
74:(
69:)
65:(
51:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
